Yunnun Druos Works · 66-41 · CHINA
For Yunnun Druos Works, import alert is 66-41; country is CHINA; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; product is Ginseng She Lian Wan Capsules | Ginseng She Lian Wan Capsules | Ginseng She Lian Wan Capsules | Ginseng She Lian Wan Capsules | Ginseng She Lian Wan Capsules; product code is 54 Y - - 04 Ginseng Unconventional Dietary Speciality for Humans or Animals | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 61 X - - 08 Chlorpheniramine Maleate (Anti-Histaminic) | 64 L - - 19 Dexamethasone (Glucocorticoid) | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 06/16/2015; address is 389 Xin Yang Rd. , Yunnun, CHINA, verified against its source on 2026-10-01.
- Firm
- Yunnun Druos Works verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- CHINA verified
- Address
- 389 Xin Yang Rd. , Yunnun, CHINA verified
- Date published
- 06/16/2015 verified
- Product code
- 54 Y - - 04 Ginseng Unconventional Dietary Speciality for Humans or Animals | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 61 X - - 08 Chlorpheniramine Maleate (Anti-Histaminic) | 64 L - - 19 Dexamethasone (Glucocorticoid) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- Ginseng She Lian Wan Capsules | Ginseng She Lian Wan Capsules | Ginseng She Lian Wan Capsules | Ginseng She Lian Wan Capsules | Ginseng She Lian Wan Capsules each item verified
- FDA notes
- The aforementioned product appears to be an unapproved new drug as FDA analysis found undeclared chlorpheniramine and dexamethasone in the product. In addition; the aforementioned product appears to be an unapproved new drug as the product label implies the product is intended for use in the diagnosis; cure; mitigation; treatment; or prevention of disease. Examples of the product's intended use from the product label include but are not limited to the following; 'INDICATIONS; Traditionally use for lumbago; gout; arthrodynia; myasthenia; limb numbness; pains induced by acclimation fever and rheumatism; osteocope and arthritis'. | The aforementioned product appears to be an unapproved new drug as FDA analysis found undeclared chlorpheniramine and dexamethasone in the product. In addition; the aforementioned product appears to be an unapproved new drug as the product label implies the product is intended for use in the diagnosis; cure; mitigation; treatment; or prevention of disease. Examples of the product's intended use from the product label include but are not limited to the following; 'INDICATIONS; Traditionally use for lumbago; gout; arthrodynia; myasthenia; limb numbness; pains induced by acclimation fever and rheumatism; osteocope and arthritis'. | The aforementioned product appears to be an unapproved new drug as FDA analysis found undeclared chlorpheniramine and dexamethasone in the product. In addition; the aforementioned product appears to be an unapproved new drug as the product label implies the product is intended for use in the diagnosis; cure; mitigation; treatment; or prevention of disease. Examples of the product's intended use from the product label include but are not limited to the following; 'INDICATIONS; Traditionally use for lumbago; gout; arthrodynia; myasthenia; limb numbness; pains induced by acclimation fever and rheumatism; osteocope and arthritis'. | The aforementioned product appears to be an unapproved new drug as FDA analysis found undeclared chlorpheniramine and dexamethasone in the product. In addition; the aforementioned product appears to be an unapproved new drug as the product label implies the product is intended for use in the diagnosis; cure; mitigation; treatment; or prevention of disease. Examples of the product's intended use from the product label include but are not limited to the following; 'INDICATIONS; Traditionally use for lumbago; gout; arthrodynia; myasthenia; limb numbness; pains induced by acclimation fever and rheumatism; osteocope and arthritis'. | The aforementioned product appears to be an unapproved new drug as FDA analysis found undeclared chlorpheniramine and dexamethasone in the product. In addition; the aforementioned product appears to be an unapproved new drug as the product label implies the product is intended for use in the diagnosis; cure; mitigation; treatment; or prevention of disease. Examples of the product's intended use from the product label include but are not limited to the following; 'INDICATIONS; Traditionally use for lumbago; gout; arthrodynia; myasthenia; limb numbness; pains induced by acclimation fever and rheumatism; osteocope and arthritis'. each item verified
What the source says
Yunnun Druos Works Date Published : 06/16/2015 389 Xin Yang Rd. , Yunnun, CHINA
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
54 Y - - 04 Ginseng Unconventional Dietary Speciality for Humans or Animals Date Published: 06/16/2015 Desc: Ginseng She Lian Wan Capsules Notes: The aforementioned product appears to be an unapproved new drug as FDA analysis found undeclared chlorpheniramine and dexamethasone in the product. In addition; the aforementioned product appears to be an unapproved new drug as the product label implies the product is intended for use in the diagnosis; cure; mitigation; treatment; or prevention of disease. Examples of the product's intended use from the product label include but are not limited to the following; 'INDICATIONS; Traditionally use for lumbago; gout; arthrodynia; myasthenia; limb numbness; pains induced by acclimation fever and rheumatism; osteocope and arthritis'. 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 06/16/2015 Desc: Ginseng She Lian Wan Capsules Notes: The aforementioned product appears to be an unapproved new drug as FDA analysis found undeclared chlorpheniramine and dexamethasone in the product. In addition; the aforementioned product appears to be an unapproved new drug as the product label implies the product is intended for use in the diagnosis; cure; mitigation; treatment; or prevention of disease. Examples of the product's intended use from the product label include but are not limited to the following; 'INDICATIONS; Traditionally use for lumbago; gout; arthrodynia; myasthenia; limb numbness; pains induced by acclimation fever and rheumatism; osteocope and arthritis'. 61 X - - 08 Chlorpheniramine Maleate (Anti-Histaminic) Date Published: 06/16/2015 Desc: Ginseng She Lian Wan Capsules Notes: The aforementioned product appears to be an unapproved new drug as FDA analysis found undeclared chlorpheniramine and dexamethasone in the product. In addition; the aforementioned product appears to be an unapproved new drug as the product label implies the product is intended for use in the diagnosis; cure; mitigation; treatment; or prevention of disease. Examples of the product's intended use from the product label include but are not limited to the following; 'INDICATIONS; Traditionally use for lumbago; gout; arthrodynia; myasthenia; limb numbness; pains induced by acclimation fever and rheumatism; osteocope and arthritis'. 64 L - - 19 Dexamethasone (Glucocorticoid) Date Published: 06/16/2015 Desc: Ginseng She Lian Wan Capsules Notes: The aforementioned product appears to be an unapproved new drug as FDA analysis found undeclared chlorpheniramine and dexamethasone in the product. In addition; the aforementioned product appears to be an unapproved new drug as the product label implies the product is intended for use in the diagnosis; cure; mitigation; treatment; or prevention of disease. Examples of the product's intended use from the product label include but are not limited to the following; 'INDICATIONS; Traditionally use for lumbago; gout; arthrodynia; myasthenia; limb numbness; pains induced by acclimation fever and rheumatism; osteocope and arthritis'. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 06/16/2015 Desc: Ginseng She Lian Wan Capsules Notes: The aforementioned product appears to be an unapproved new drug as FDA analysis found undeclared chlorpheniramine and dexamethasone in the product. In addition; the aforementioned product appears to be an unapproved new drug as the product label implies the product is intended for use in the diagnosis; cure; mitigation; treatment; or prevention of disease. Examples of the product's intended use from the product label include but are not limited to the following; 'INDICATIONS; Traditionally use for lumbago; gout; arthrodynia; myasthenia; limb numbness; pains induced by acclimation fever and rheumatism; osteocope and arthritis'.
— all from accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.